Abstract
The global protein therapeutics market was valued at US$57 billion in 2005.
Biotechnology has made notable inroads in the field of protein therapeutics,
resulting in some of the key products presently available in the category.
Recombinant proteins are potentially advantageous in terms of higher efficacy
and fewer side effects than other pharmaceutical products, as they can be more
specifically targeted to the cause of the disease, rather than the treatment
of its symptoms.
This report examines each of the protein therapeutics classes in turn,
assessing the market potential, and encompassing main therapeutic areas to
which they are applicable.
The following product classes are analyzed in this report:
- erythropoietins (EPO)
- interferons
- interleukins
- insulin
- monoclonal antibodies
- blood-clotting factors
- colony-stimulating factors (CSFs)
- growth hormones
- plasminogen activators
- reproductive hormones
- therapeutic enzymes
The report assesses the overall protein therapeutics market, key classes, and
the factors influencing their historical and future performance. The report
provides an overview of key products in each category, comparing their
clinical efficacy and marketing position. The overview of the current market
is given in terms of segmentation by category, by region and by leading
players and their products. Moreover, the report examines the promise of new
drugs in each class and research and development efforts aimed at improving
their delivery.
Finally, the future performance of the protein therapeutics market as a whole
is examined against the background of pricing, emerging generic competition
and manufacturing issues, indicating the likely trends in the coming years,
and identifying possible solutions for problematic issues.
Key Features of this report:
- Overview of the protein therapeutics environment, including main
therapeutic categories, drug delivery technologies and key players
- In-depth analysis of different classes of protein therapeutics, including
key drugs in major therapeutic areas, as well as their advantages and
disadvantages
- Comprehensive facts and figures for the protein therapeutics market,
including main players and regional break-downs
- Future trends in the protein therapeutics marketplace, shaped by medical
and technological advances as well as demographic and epidemiological changes
and industry needs
- Outlook for the protein therapeutics market, including manufacturing
considerations and research into new methods of protein delivery
Who should buy this report?
- Companies with a need to understand the protein therapeutics market and
its place in the modern pharmaceutical industry
- Companies interested in understanding the impact and implications of
product placement, lifecycle management and competition in the protein
therapeutics marketplace
- Companies interested in understanding future opportunities in the protein
therapeutics sector provided by a combination of factors, including changing
demographics and financial issues
- Pharma/biotech companies wishing to identify potential protein
therapeutics areas for partnerships and collaboration in order to examine a
variety of profit maximization strategies
View Cart
